EPAS1 and neoplasm: In colorectal cancer, EPAS1 expression was negatively correlated with tumor grades, and mRNA expression of EPAS1 was significantly lower in primary colorectal cancer tissues than in healthy tissues and correlated with advanced pathological stages III and IV and poor patient survival (51, 52).